Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Document Type

Letter to the Editor

Publication Date

9-1-2021

Journal

Infectious Diseases and Therapy

Volume

10

Issue

3

DOI

10.1007/s40121-021-00443-5

Keywords

COVID-19; Mortality benefit; Steroids; Tocilizumab

This document is currently not available here.

Share

COinS